Clinical Trial Update: Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating immune response and safety of a DTPw-HBV/Hib booster vaccine given at 15-18 months; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Disease
• Hepatitis B
• Pertussis
• Tetanus

Drugs mentioned

• DTPw-HBV/Hib vaccine (Diphtheria and Tetanus Toxoids and Whole-Cell Pertussis vaccine, with Hepatitis B and Haemophilus influenzae type b)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hib Disease, Hepatitis B | Phase 2 | Status: COMPLETED